Stephen LaCorte, J.D.

Stephen is an attorney residing in Houston, Texas, who worked in the oil and gas industry.  In 2013 he was prescribed Klonopin for trouble sleeping.  Within 3 weeks of being on the drug, he developed new symptoms, including emotional blunting and daytime sedation.  He was fortunate to locate a benzodiazepine aware physician who began assisting him with his taper off of Klonopin.  Stephen was made aware of the benzodiazepine initiative in Massachusetts and became interested in raising awareness of the same in Texas.  Stephen joined Benzodiazepine Information Coalition as a director in September, 2016.




Upjohn Study Shows Xanax (Alprazolam) Impairs Recovery from Panic Disorder and Agoraphobia

Dr. Isaac Marks and Dr. Richard Swinson led a study to determine the efficacy of the benzodiazepine class drug, alprazolam, marketed under the brand name, Xanax, by its developer, Upjohn.  The Marks and Swinson study was published in the British Journal of Psychiatry...

read more